Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines. | Life (Basel) | 2024 | 38255708 | PubTator, text mining | PubMed |
| MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. | Cancers (Basel) | 2024 | 38254750 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. | Pathogens | 2024 | 38251375 | PubTator, text mining | PubMed |
| Unique Genetic Features of Lean NAFLD: A Review of Mechanisms and Clinical Implications. | J Clin Transl Hepatol | 2024 | 38250459 | PubTator, text mining | PubMed |
| Endpoints in NASH Clinical Trials: Are We Blind in One Eye? | Metabolites | 2024 | 38248843 | PubTator, text mining | PubMed |
| Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice. | J Pers Med | 2024 | 38248762 | PubTator, text mining | PubMed |
| The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease. | Antioxidants (Basel) | 2024 | 38247511 | PubTator, text mining | PubMed |
| LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. | Sci Rep | 2024 | 38233470 | PubTator, text mining | PubMed |
| Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model. | Sci Rep | 2024 | 38228622 | PubTator, text mining | PubMed |
| Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women. | Clin Transl Med | 2024 | 38224202 | PubTator, text mining | PubMed |
| Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2024 | 38222031 | PubTator, text mining | PubMed |
| Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD. | Clin Gastroenterol Hepatol | 2024 | 38216023 | PubTator, text mining | PubMed |
| What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. | J Clin Med | 2024 | 38202285 | PubTator, text mining | PubMed |
| Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations. | Genome Med | 2024 | 38200577 | PubTator, text mining | PubMed |
| Sleep patterns, genetic predisposition, and risk of chronic liver disease: A prospective study of 408,560 UK Biobank participants. | J Affect Disord | 2024 | 38199417 | PubTator, text mining | PubMed |
| Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence. | Cell Commun Signal | 2024 | 38195552 | PubTator, text mining | PubMed |
| Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis. | Metabol Open | 2024 | 38187470 | PubTator, text mining | PubMed |
| Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‑alcoholic fatty liver disease. | Int J Mol Med | 2024 | 38186319 | PubTator, text mining | PubMed |
| Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study. | EClinicalMedicine | 2024 | 38169797 | PubTator, text mining | PubMed |
| Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use. | Nat Commun | 2024 | 38167725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=23